ALIGN TECHNOLOGY, INC. Proceeds from Collection of Notes Receivable
ALIGN TECHNOLOGY, INC. (ALGN) reported Proceeds from Collection of Notes Receivable of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2024-02-28
- ALIGN TECHNOLOGY, INC. proceeds from collection of notes receivable for the quarter ending 2022-12-31 was $0.00.
- ALIGN TECHNOLOGY, INC. proceeds from collection of notes receivable for the quarter ending 2022-09-30 was $0.00.
- ALIGN TECHNOLOGY, INC. proceeds from collection of notes receivable for the quarter ending 2022-06-30 was $0.00.
- ALIGN TECHNOLOGY, INC. proceeds from collection of notes receivable for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. proceeds from collection of notes receivable for fiscal 2023 was $0.00.
- ALIGN TECHNOLOGY, INC. proceeds from collection of notes receivable for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- ALIGN TECHNOLOGY, INC. proceeds from collection of notes receivable for fiscal 2021 was $4.59M, a 82.94% decline from fiscal 2020.
- ALIGN TECHNOLOGY, INC. proceeds from collection of notes receivable for fiscal 2020 was $26.93M, a 23.40% increase from fiscal 2019.
| Period end | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month | Proceeds from Collection of Notes Receivable 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $4.59M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $4.59M 10-Q · filed 2022-11-04 | $13.69M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.59M 10-Q · filed 2022-08-04 | $13.69M derived: sum of 3 quarters · filed 2023-02-27 | $20.43M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $4.59M 10-Q · filed 2022-05-05 | $13.69M derived: sum of 2 quarters · filed 2023-02-27 | $20.43M derived: sum of 3 quarters · filed 2023-02-27 | $27.10M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $15.84M derived: sum of 2 quarters · filed 2023-02-27 | $22.51M derived: sum of 3 quarters · filed 2023-02-27 | $26.93M 10-K · filed 2023-02-27 |
| 2020-09-30 | $6.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $13.41M derived: sum of 2 quarters · filed 2021-11-02 | $17.83M 10-Q · filed 2021-11-02 | $26.46M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $6.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $11.09M 10-Q · filed 2021-08-04 | $19.72M derived: sum of 3 quarters · filed 2022-02-25 | $26.31M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $4.42M 10-Q · filed 2021-05-05 | $13.05M derived: sum of 2 quarters · filed 2022-02-25 | $19.64M derived: sum of 3 quarters · filed 2022-02-25 | $26.24M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $8.63M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $15.22M derived: sum of 2 quarters · filed 2022-02-25 | $21.82M derived: sum of 3 quarters · filed 2022-02-25 | $21.82M 10-K · filed 2022-02-25 |
| 2019-09-30 | $6.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $13.19M derived: sum of 2 quarters · filed 2020-10-30 | $13.19M 10-Q · filed 2020-10-30 | $13.19M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $6.60M 10-Q · filed 2020-07-31 | $6.60M derived: sum of 3 quarters · filed 2021-02-26 | $6.60M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-05 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 10-K · filed 2021-02-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-01 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |